The Longevity Stack: What Epitalon, NAD+ and MOTS-c Are Actually Doing

Longevity is the fastest-growing category in research peptides, and three compounds anchor almost every protocol being discussed in serious research communities: Epitalon, NAD+, and MOTS-c. Each targets a different aging pathway — telomere maintenance, cellular energy metabolism, and mitochondrial signaling — and together they form what researchers in the field call the foundational stack.

Epitalon is a four-amino-acid peptide studied for its effects on the pineal gland and telomere length. Decades of Russian clinical research and a growing body of independent work have made it a staple in any structured longevity protocol. Researchers cycle it in 10–20 day windows, and the 10-vial wholesale kit comfortably covers a full annual cadence.

NAD+ supplementation has moved from biohacker novelty to mainstream research interest. The molecule is central to mitochondrial function, DNA repair, and sirtuin activation — three of the most-studied aging pathways in the literature. The wholesale kit format makes the cost-per-protocol genuinely accessible for serious researchers.

MOTS-c, a mitochondrial-derived peptide, is the newcomer. Research is still building, but the early signals on metabolic health, insulin sensitivity and exercise capacity are why it's being added to longevity protocols across the research community. For resellers, the longevity category is the highest customer-lifetime-value segment in the catalog — repeat buyers, structured cycles, and a customer base that values documentation.